EPI Health and MC2 Therapeutics Announce Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) now covered on Express Scripts National Preferred Formulary
Charleston, S.c. and Copenhagen, Denmark (ots/PRNewswire) - Wynzora® Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older. EPI Health, LLC, a specialty pharmaceutical company committed to delivering innovative ...
plus